Showing 961 - 980 results of 1,800 for search '(( 50 ((ms decrease) OR (a decrease)) ) OR ((( a system decrease ) OR ( a 10 decrease ))))*', query time: 0.17s Refine Results
  1. 961
  2. 962
  3. 963
  4. 964

    Magnetorheological elastomer-based variable stiffness flexible coupling for vibration isolation by Syam, Thaer M.I.

    Published 2021
    “…Our results show that the level of vibration decreased when the magnetic field increased. The first natural frequency of the system happened at 26 Hz and moved to 28 Hz when the applied magnetic field increased from 0 to 12.38 mT. …”
    Get full text
    Get full text
  5. 965

    Awareness of disabilities in pharmacy program recruitment material: are we doing enough? by Hussain, Farhat Naz

    Published 2020
    “…Introduction: Targeted recruitment of students with disabilities is a novel area in pharmacy education and may help to attract qualified students in light of decreasing applicant numbers. …”
    Get full text
    Get full text
  6. 966

    Gas solubility and rheological behavior study of betaine and alanine based natural deep eutectic solvents (NADES) by Altamash T.

    Published 2018
    “…A pressure driven physisorption mechanism was observed for the studied systems. …”
    Get full text
    Get full text
  7. 967
  8. 968
  9. 969
  10. 970

    Morphology and property changes in PLA/PHBV blends as function of blend composition by Kanda G.S.

    Published 2018
    “…wt.% PHBV. For samples between 50/50 and 10/90 PLA/PHBV the tensile strength and Young?…”
    Get full text
    Get full text
  11. 971

    Does Securitisation Make Monetary Policy Less Effective? by Qanas, Jalal

    Published 2021
    “…We empirically investigate the interactions between securitisation activities and monetary policy using data from 1995 to 2015 for a panel of 10 European countries. We employ a panel VAR model, and estimate it using a GMM system. …”
    Get full text
    Get full text
    Get full text
  12. 972
  13. 973
  14. 974

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus by Dimitrios, Patoulias

    Published 2023
    “…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …”
    Get full text
    Get full text
    Get full text
  15. 975
  16. 976
  17. 977
  18. 978
  19. 979
  20. 980